Home › Alpha-1 Antitrypsin Deficiency › Colorado
Alpha-1 Antitrypsin Deficiency clinical trials in Colorado
3 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in Colorado.
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Peak Gastroenterology Associates, PC, Colorado Springs
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated May 13, 2026 · NCT05677971Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- Peak Gastroenterology Associates, Colorado Springs
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 5, 2026 · NCT06165341PiMZ Longitudinal Cohort (PiMZ Logic)
- National Jewish Health, Denver
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT06505603From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.